captopril has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, XL; Sha, NN; Shi, Q; Shu, B; Wang, XL; Wang, YJ; Wong, MS; Xiao, HH; Zhang, Y; Zhao, YJ | 1 |
| Ng, SC; Yoon, KH | 1 |
2 other study(ies) available for captopril and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Differential response of bone and kidney to ACEI in db/db mice: A potential effect of captopril on accelerating bone loss.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone and Bones; Bone Resorption; Calcium; Captopril; Diabetes Mellitus, Experimental; Femur; Fibrosis; Kidney; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Renin-Angiotensin System; RNA, Messenger; Tibia; Vitamin D3 24-Hydroxylase; X-Ray Microtomography | 2017 |
Calcitonin and mandibular bone resorption in systemic sclerosis.
Topics: Bone Resorption; Calcitonin; Captopril; Female; Humans; Jaw; Mandible; Middle Aged; Pain; Prednisolone; Radiography, Thoracic; Scleroderma, Systemic | 1999 |